HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: AJPH.2004.053306v1 96/4/691    most recent Submit a response View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Santibanez, T. A. Articles by Barker, L. E. Search for Related Content PubMed PubMed Citation Articles by Santibanez, T. A. Articles by Barker, L. E. Related Collections Immunization/Vaccines

Tammy A. Santibanez, PhD, Jeanne M. Santoli, MD, MPH and Lawrence E. Barker, PhD

The authors are with the Centers for Disease Control and Prevention, Atlanta, Ga.

Correspondence: Requests for reprints should be sent to Tammy A. Santibanez, PhD, Centers for Disease Control and Prevention, National Immunization Program, 1600 Clifton Rd, NE, Mail Stop E-62, Atlanta, GA 30333 (afz5{at}cdc.gov).

Objectives. We determined the effect of diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP) and measles, mumps, rubella (MMR) vaccine shortages on timeliness of the third dose of DTaP (DTaP3), the fourth dose of DTaP (DTaP4), and the first dose of MMR (MMR1) among subgroups of preschool children.

Methods. Data from the 2001 and 2002 National Immunization Surveys were analyzed. Children age-eligible to receive DTaP3, DTaP4, or MMR1 during the shortages were considered subject to the shortage, and those not age-eligible were not subject to the shortage; timeliness of vaccinations was compared.

Results. Among children vaccinated only at public clinics, children residing outside metropolitan statistical areas, and children in the Southern Census Region, those age-eligible to receive DTaP4 during the shortage were less likely to be vaccinated by 19 months of age than children not subject to the shortage.

Conclusions. There was notable disparity in the effects of the recent vaccine shortages; children vaccinated only in public clinics, in rural areas, or in the Southern United States were differentially affected by the shortages.

This article has been cited by other articles:

				L. McQuillan, M. F. Daley, S. Stokley, L. A. Crane, B. L. Beaty, J. Barrow, C. Babbel, L. M. Dickinson, and A. Kempe Impact of the 2004-2005 Influenza Vaccine Shortage on Pediatric Practice: A National Survey Pediatrics, February 1, 2009; 123(2): e186 - e192. [Abstract] [Full Text] [PDF]

				H. Groom, A. Bhatt, M. L. Washington, and J. Santoli Temporary Vaccine Recommendations and Provider Compliance: A Survey of Pediatric Practices During the 2003-2004 Pneumococcal Conjugate Vaccine Shortage Pediatrics, October 1, 2008; 122(4): e835 - e840. [Abstract] [Full Text] [PDF]

				A. V. Groom, M. L. Washington, P. J. Smith, and R. T. Bryan Underimmunization of American Indian and Alaska Native Children Pediatrics, May 1, 2008; 121(5): 938 - 944. [Abstract] [Full Text] [PDF]

				M. J. Smith, S. S. Ellenberg, L. M. Bell, and D. M. Rubin Media Coverage of the Measles-Mumps-Rubella Vaccine and Autism Controversy and Its Relationship to MMR Immunization Rates in the United States Pediatrics, April 1, 2008; 121(4): e836 - e843. [Abstract] [Full Text] [PDF]

				A. V. Groom, J. E. Cheek, and R. T. Bryan Effect of a National Vaccine Shortage on Vaccine Coverage for American Indian/Alaska Native Children Am J Public Health, April 1, 2006; 96(4): 697 - 701. [Abstract] [Full Text] [PDF]